Keyphrases
Antimetastatic
10%
Antimetastatic Effect
22%
Antitumor Activity
8%
Antitumor Effect
10%
Apoptosis
14%
Breast Cancer
9%
Breast Cancer Cells
19%
Cancer Cells
19%
Cancer Immunotherapy
18%
Cancer Metastasis
14%
CD1d
8%
CD27
13%
Cell Death
9%
Cell-mediated
9%
Cell-to-cell
8%
Cytotoxicity
12%
Effector Function
10%
GalCer
12%
Gene-deficient Mice
7%
Hirsutine
7%
Immune Response
9%
Immune Surveillance
10%
Immune System
8%
In Cancer
11%
Interferon-α (IFN-α)
17%
Interleukin-12 (IL-12)
10%
Interleukin-21 (IL-21)
13%
Liver
15%
Liver Metastasis
11%
Lung Metastasis
8%
Macrophages
9%
Melanoma
12%
Metastasis
12%
Metastatic Potential
14%
Molecular Mechanism
8%
Natural Killer Cells
100%
NF-B
27%
NKG2D
27%
NKT Cells
32%
Non-small Cell Lung Cancer (NSCLC)
11%
Perforin
15%
T Cells
23%
Tumor
35%
Tumor Cells
20%
Tumor Growth
13%
Tumor Immunity
14%
Tumor Metastasis
16%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
29%
Tumor Rejection
11%
α-galactosylceramide (α-GalCer)
12%
Immunology and Microbiology
Angiogenesis
6%
Antiinflammatory Activity
6%
Antineoplastic Activity
12%
Bioluminescence
6%
Cancer Cell
22%
Cancer Immunotherapy
8%
Cell Activation
5%
Cell Maturation
10%
Cytokine
21%
Cytokine Production
5%
Cytotoxic T Cell
5%
Cytotoxic T-Cell
6%
Cytotoxicity
19%
Dendritic Cell
6%
Homeostasis
6%
Immune Response
14%
Immune System
5%
Immunity
13%
Immunology
12%
Immunosurveillance
19%
Immunotherapy
8%
interferon
15%
Interleukin 4
8%
Kaempferia
5%
Lymphocyte
5%
Major Histocompatibility Complex
6%
Mast Cell
5%
Maturation
9%
MHC Class I
6%
Natural Killer Cell
98%
Natural Killer T Cell
40%
NKG2D
23%
Perforin
15%
T Cell
31%
T Cell Receptor
10%
T-Helper Cell
5%
Thalidomide
5%
TNF related apoptosis inducing ligand
13%
Tumor Cell
17%
Tumor Immunity
9%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
Tumor Rejection
11%
Pharmacology, Toxicology and Pharmaceutical Science
Alkadiene
5%
Alternative Complement Pathway C3 C5 Convertase
5%
Anti-Inflammatory Drug
10%
Anticarcinogen
5%
Antiinflammatory Activity
5%
Antitumor Activity
7%
Breast Cancer
30%
Cancer Growth
7%
Cancer Model
5%
Carcinogenesis
6%
Carcinoma
6%
Cytokine
17%
Cytotoxicity
12%
Diterpenoid
7%
Epidermal Growth Factor Receptor
7%
Galactosylceramide
11%
Hirsutine
7%
Immunotherapy
9%
Infection
5%
Inflammation
11%
Interferon
9%
Interleukin 6
7%
Kaempferia
10%
Kampo Medicine (Drug)
5%
Liver Metastasis
8%
Luciferase
5%
Lung Cancer
17%
Lung Metastasis
9%
Malignant Neoplasm
39%
Melanoma
16%
Metastasis
30%
Metastasis Potential
10%
Morus Alba
5%
Natural Product
6%
Neoplasm
46%
Non Small Cell Lung Cancer
12%
Nuclear Factor
6%
Paclitaxel
5%
Perforin
7%
Phytochemical
7%
Receptor
6%
SARS Coronavirus
5%
Shi Quan Da Bu Tang
5%
Thalidomide
5%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
